BMRN: Biomarin Pharmaceutical Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
566 institutions reported holding $10.97B of Biomarin Pharmaceutical Inc on Form 13F (560 the quarter before). 82 opened a new position and 77 sold out. Shares held by institutions: +7%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 20,445,212 | $1.17B |
| Dodge & Cox | 14,844,930 | $849.43M |
| PRIMECAP MANAGEMENT CO/CA/ | 14,190,183 | $811.96M |
| VANGUARD CAPITAL MANAGEMENT LLC | 8,743,633 | $500.31M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,648,678 | $494.88M |
| NORGES BANK | 8,207,954 | $469.66M |
| STATE STREET CORP | 7,800,959 | $446.37M |
| VIKING GLOBAL INVESTORS LP | 7,616,563 | $435.82M |
| Vestal Point Capital, LP | 6,025,000 | $344.75M |
| AQR CAPITAL MANAGEMENT LLC | 5,699,541 | $322.54M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.